Azacitidine
Vidaza · Hypomethylating agent
Renal tubular acidosis and rare AKI.
ATNFANCLYTE
ModerateOpen →
The Drug Explorer
Search the nephrotoxic landscape
A live index of 240+ anti-cancer agents, cross-filterable by injury signature, drug class, nephron segment, severity, and era. Profiled agents open to a full citation-grounded page; the rest are catalog entries with their signature kidney signal.
7 agents · filtered from 240
Profile
Ifosfamide
Ifex · Oxazaphosphorine alkylator
Chloroacetaldehyde → Fanconi syndrome.
FANCATNLYTE
SevereOpen →
Imatinib
Gleevec · BCR-ABL TKI
Fluid retention; rare Fanconi and AKI.
LYTEFANCATN
MildOpen →
Lenalidomide
Revlimid · Immunomodulatory drug (IMiD)
Renally cleared; AKI and rare Fanconi/TMA.
ATNFANCTMA
ModerateOpen →
Nirogacestat
Ogsiveo · Gamma-secretase inhibitor
2023 desmoid-tumor agent; phosphate/electrolyte disturbance.
LYTEFANC
MildOpen →
Streptozocin
Zanosar · Nitrosourea alkylator
Classic proximal tubular toxin → Fanconi and dose-limiting AKI.
FANCATNLYTE
SevereOpen →
Trastuzumab deruxtecan
Enhertu · Antibody-drug conjugate (HER2/DXd)
Emerging AKI/proteinuria reports — under-published.
ATNFANCLYTE
ModerateOpen →